EKF Diagnostics (EKF) Share Price, News & Analysis

Company Overview

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Key Stats

• Today's Range: 26 to 26.19
• 50-Day Range: 24 to 28.40
• 52-Week Range: 23 to 34
• Volume: 85,000 shs
• Average Volume: 170,876 shs
• Market Capitalization: £118.81 million
• P/E Ratio: 2,618.50
• Dividend Yield: 3.82%
• Price Target: N/A
• Consensus Rating: N/A

EKF Stock Analysis - Frequently Asked Questions

How have EKF shares performed this year?

EKF Diagnostics' stock was trading at GBX 27 at the start of the year. Since then, EKF shares have decreased by 3.0% and is now trading at GBX 26.19.
View the best growth stocks for 2025 here.

How do I buy shares of EKF Diagnostics?

Shares of EKF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of EKF Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EKF Diagnostics investors own include ERBA Diagnostics (ERBA), boohoo group (BOO), Lloyds Banking Group (LLOY), 888 (888), Abcam (ABC), ASOS (ASC) and Babcock International Group (BAB).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:EKF
• CUSIP: N/A
• CIK: N/A
• Web: www.ekfdiagnostics.com
• Phone: +44-29-20710570
• Fax: N/A
• Employees: 356
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 0.01
• Trailing P/E Ratio: 2,570.00
• Forward P/E Ratio: 11.18
• P/E Growth: N/A
• Net Income: £4.78 million
• Net Margins: 9.37%
• Pretax Margin: N/A
• Return on Equity: 7.58%
• Return on Assets: 5.27%

Debt

• Debt-to-Equity Ratio: 1.78
• Current Ratio: 4.59
• Quick Ratio: 1.77

Sales & Book Value

• Annual Sales: £50.95 million
• Price / Sales: 2.29
• Cash Flow: GBX 2.42 per share
• Price / Cash Flow: 10.64
• Book Value: GBX 15 per share
• Price / Book: 1.71

Miscellaneous

• Outstanding Shares: 453,730,000
• Free Float: N/A
• Market Cap: £116.61 million
• Optionable: Not Optionable
• Beta: 0.57